According to data from the BSE index, the stock has achieved multibagger gains over the last two years, climbing 122.04%.

Mylan and Novo Nordisk have reached a confidential settlement over the generic version of Ozempic, with Natco Pharma holding ...

“Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement of the US patent litigation related to generic Ozempic ...

Mylan Pharmaceuticals Inc and Novo Nordisk, the original patent holder for Ozempic, have reached a settlement in the US ...

NATCO Pharma Ltd announced that Mylan Pharmaceuticals Inc has settled a lawsuit with Novo Nordisk in the US concerning the ...

The United States may have reached a turning point in its decades-long battle against obesity. Recent data suggests that 2020 ...

Now with a better view of how the medication is affecting behavior, packaged-food companies are trying to profit off of the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The State Health Plan's decision to end coverage of certain weight-loss prescription drugs has produced an unlikely and ...

Over the summer, we took a deep dive into “Ozempic Face,” a phenomenon that occurs when quick, significant weight loss leads ...

While seeking re-election, the mayor of Rio de Janeiro is making a huge campaign promise: free Ozempic for all. As Quartz ...

"Americans are fat and getting fatter," wrote Reason's Ron Bailey in a March 2023 piece about obesity and the hope such ...